Steven Gannon, Director at Xenon Pharmaceuticals Inc. (XENE), sold 3 shares at $30.48 ($91) on 2025-06-05, disclosed to the SEC on 2025-06-06.
Open-market sale of $91 XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FUSN | BUY | 2022-08-11 | $180K | — | Filing → |
| FUSN | BUY | 2021-08-23 | $23K | — | Filing → |
| FUSN | BUY | 2021-08-20 | $26K | — | Filing → |